Aura Biosciences, Inc. (AURA) vs MiMedx Group, Inc. (MDXG)

A side-by-side comparison of Aura Biosciences, Inc. and MiMedx Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AURA vs MDXG

growth of $100 · dividends reinvested · last 5y
AURA -58.0% (-15.9%/yr)MDXG -35.1% (-8.3%/yr)MDXG compounded faster over this window
50100150Start $10020222023202420252026$42$65
AURA MDXG

AURA vs MDXG: by the numbers

  • •MDXG is the larger company ($665M vs $641M market cap).
  • •MDXG is profitable (1.76% net margin) while AURA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAURAMDXG
P/E ratioN/A114.13
P/S ratioN/A1.87
P/B ratio2.033.08
EV / EBITDAN/A26.02
FCF yieldN/A6.10%

Profitability

MetricAURAMDXG
Gross margin0.00%78.85%
Operating margin0.00%15.26%
Net margin0.00%1.76%
ROE-41.56%2.89%
ROIC-42.02%1.97%

Growth (annualized)

MetricAURAMDXG
Revenue CAGR (5Y)N/A6.36%
Total return CAGR (5Y)N/A-4.94%

Frequently asked

Is AURA or MDXG more profitable?
MDXG runs the higher net margin — AURA at 0.00% versus MDXG at 1.76%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.